Developing diagnostic tests to screen for sepsis and impaired hemostasis.
Industry: Health Care
First Day Return: +30.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 07/02/2014 |
Offer Price | $11.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 5.2 |
Deal Size ($mm) | $57 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 08/06/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $57 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Lexington, MA, United States |
Founded | 2006 |
Employees at IPO | 68 |
Website www.t2biosystems.com |